NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £1,833,333,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 24 Nov 2023 |
| Procedure | open |
| OCID | ocds-h6vhtk-040e74 |
Awards (77)
This procurement was awarded to 41 suppliers. Values shown are per-award; the notice total is £1,833,333,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Abbvie Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Abbvie Ltd shared | · | · | active |
| Accord-UK Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Accord-UK Ltd shared | · | · | active |
| Almirall shared | £688,010,000 | 26 Jan 2024 | active |
| Almirall shared | · | · | active |
| Amgen Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Amgen Ltd shared | · | · | active |
| AstraZeneca shared | £688,010,000 | 26 Jan 2024 | active |
| AstraZeneca shared | · | · | active |
| Aventis Pharma ltd t/a Sanofi shared | £688,010,000 | 26 Jan 2024 | active |
| Aventis Pharma ltd t/a Sanofi shared | · | · | active |
| Bayer Plc shared | £688,010,000 | 26 Jan 2024 | active |
| Bayer Plc shared | · | · | active |
| Biogen shared | £688,010,000 | 26 Jan 2024 | active |
| Biogen shared | · | · | active |
| Celltrion Healthcare United Kingdom Limited shared | £688,010,000 | 26 Jan 2024 | active |
| Celltrion Healthcare United Kingdom Limited shared | · | · | active |
| Chugai Pharma UK Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Chugai Pharma UK Ltd shared | · | · | active |
| CST Pharma Limited shared | £688,010,000 | 26 Jan 2024 | active |
| CST Pharma Limited shared | · | · | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £688,010,000 | 26 Jan 2024 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | · | · | active |
| Eli Lilly and Company Ltd shared | · | · | active |
| Eli Lilly & Company Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Galapagos Biotech Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Galapagos Biotech Ltd shared | · | · | active |
| Gedeon Richter UK Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Gedeon Richter UK Ltd shared | · | · | active |
| GlaxoSmithKline UK Limited shared | £688,010,000 | 26 Jan 2024 | active |
| GlaxoSmithKline UK Limited shared | · | · | active |
| Ipsen shared | £688,010,000 | 26 Jan 2024 | active |
| Ipsen shared | · | · | active |
| Janssen-Cilag Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Janssen-Cilag Ltd shared | · | · | active |
| Kent Pharma Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Merck Serono Limited shared | £688,010,000 | 26 Jan 2024 | active |
| Merck Serono Limited shared | · | · | active |
| Merck Sharpe and Dohme (UK) Limited shared | · | · | active |
| Merck Sharpe & Dohme (UK) Limited shared | £688,010,000 | 26 Jan 2024 | active |
| Merz shared | £688,010,000 | 26 Jan 2024 | active |
| Merz shared | · | · | active |
| Mylan shared | £688,010,000 | 26 Jan 2024 | active |
| Mylan shared | · | · | active |
| Napp Pharmaceuticals Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Napp Pharmaceuticals Ltd shared | · | · | active |
| Neon Healthcare Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Neon Healthcare Ltd shared | · | · | active |
| Novartis Pharmaceuticals UK Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Novartis Pharmaceuticals UK Ltd shared | · | · | active |
| Novo Nordisk shared | £688,010,000 | 26 Jan 2024 | active |
| Novo Nordisk shared | · | · | active |
| Organon Pharmaceuticals UK Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Organon Pharmaceuticals UK Ltd shared | · | · | active |
| Orifarm UK shared | £688,010,000 | 26 Jan 2024 | active |
| Orifarm UK shared | · | · | active |
| Pfizer Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Pfizer Ltd shared | · | · | active |
| Pharmacosmos UK Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Pharmacosmos UK Ltd shared | · | · | active |
| Roche Products Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Roche Products Ltd shared | · | · | active |
| Sandoz Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Sandoz Ltd shared | · | · | active |
| Sobi (Swedish Orphan Biovitrum Ltd) shared | £688,010,000 | 26 Jan 2024 | active |
| Sobi (Swedish Orphan Biovitrum Ltd) shared | · | · | active |
| Sun Pharma UK Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Sun Pharma UK Ltd shared | · | · | active |
| Teva UK Limited shared | £688,010,000 | 26 Jan 2024 | active |
| Teva UK Limited shared | · | · | active |
| Thornton and Ross Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Thornton and Ross Ltd shared | · | · | active |
| Vifor Pharma UK Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Vifor Pharma UK Ltd shared | · | · | active |
| Zentiva Pharma UK Ltd shared | £688,010,000 | 26 Jan 2024 | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024<br/> <br/>Offer reference number: CM/PHR/22/5678<br/> <br/>CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months<br/><br/>CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months
documents
- https://www.contractsfinder.service.gov.uk/Notice/5f1c8860-43f3-4566-8ce3-972bf748fb21 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/7840f7a2-64cf-44e7-93ef-1e7c6e4dc732 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/83e9c973-5f65-40a3-b4c4-a26996285d57 , tenderNotice
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/0239a52b-4450-477f-981e-f8c21392d108
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/075daf6b-f03d-4ec7-87af-f9102bee4370
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/07ffa7e7-7e47-488f-aa8e-a97bb178e9f3
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/0b96c10a-7b04-48ad-9ceb-0e8753e8711e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/0cd75c76-2a55-4f02-9997-37d33a28f6a9
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/0dea3890-aca8-4f4f-9dc1-8284bab55077
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/138a6529-4440-4241-a620-f65b4a815c6a
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/180f29a5-e466-4592-8c0b-241c6752bcbb
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/18c14f4a-cd4a-4c1c-ab39-777ef9407924
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/1c38cf89-7ddd-4ea7-a16e-c906351dde78
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/1e26b303-f228-4b5a-a94a-4bb6f32b8d39
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/20aa7ca4-f8a5-47e9-9f44-4f52d860a5ba
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2125b84b-2bc4-476b-8b2d-732617711bce
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/232d3f8d-4698-4e77-8975-03243ad9daf6
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/23c3a1ef-568c-4dca-a282-7d4c42cd6bc5
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2619727a-10de-4fcf-b61c-60cc9c97e3aa
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/271859ac-d3f2-4720-ac81-6d5b16fa912e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2a4065b7-0c5d-408a-9289-519e6e19f1b4
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/2b6ab6e1-cf12-43c4-b4ce-7e9984468d47
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/300e5eb5-0874-49bc-a908-aa6901f4fd99
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/30607c2a-2cfd-4094-8ab9-0c2a98e99fc4
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/317590a5-1305-47ff-a082-5c56ce3ca594
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/38d20490-d812-498e-a398-fb22e4746a06
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/3b3a745d-3b1b-44de-9202-6bad9e61cbfc
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/3bfda61f-415d-44a1-b813-c223cbe2b4aa
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/419eb52a-6fdd-40e1-8086-d3137f03efb3
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/419f4168-24a8-4a3f-9436-64957054d827
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/4610a5c4-d789-4e86-aa24-67b5d02c0eae
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/4714edd3-972d-40a9-9446-bf883ae42a55
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/473c3115-e191-410d-b9f2-d2457b2b3ec2
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/47cd16d0-c1ea-4284-beec-55a7767ed088
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/4a827b4c-59fd-4c1f-9ce4-c507d8889433
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/4dc04b49-2977-4aa3-8c21-8dcaa0f5d05c
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/50710ff7-a384-4bc7-adbd-076489620b23
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/5f5702ae-9e2b-4fe1-883e-96e10d6ea48e
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/609017b4-c045-423b-a18d-cbf7e3353d90
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/6446fcc6-b5b5-434a-bfe4-bc7fd75daf46
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/6490e2fb-94bd-4c9b-aefd-49ed0ecf7afd
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/68cfd58a-456d-4acd-b881-4c7f7e11adcc
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/6a132171-845e-4866-924b-d1ef5905aaa6
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/6b535a75-fdfb-49f6-8eb3-b318f194c05b
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/76152db5-4023-4130-b4de-0603b0dc9bdf
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/806e59b7-b022-414f-8f63-c32bd139aa9b
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/827c638b-d84b-4031-bb11-6fa954ff1fba
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/85d4eea6-341f-48f5-af93-8111016cf1a5
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/8787c4e2-84e7-4db7-875f-71dc92d316ca
- https://www.contractsfinder.service.gov.uk/Notice/Attachment/886c93f7-a4d7-45d0-9f50-bf7737a3eb00
Documents are linked, not mirrored. They are served by the publishing authority and may require registration.
notice history
5 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 24 Oct 2023 | Corrigendum (F14) | Earlier regulations | 031307-2023 |
| 24 Oct 2023 | Contract notice (F02) | Earlier regulations | 031292-2023 |
| 24 Oct 2023 | Tender (tender) | · | d51de4ea-16e3-4248-bd30-b514ae5ed833-691651 |
| 26 Feb 2024 | Contract award notice (F03) | Earlier regulations | 006097-2024 |
| 26 Feb 2024 | Award (award) | · | c7b18c5b-1199-4503-86c0-f922d2e06c42-726527 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.